companies innovating obesity treatment glp-1 drugs 2025 Market Overview: Agonists and the Market | Blog The future of GLP-1s: Cost,

Find the Best Option for Your Weight Management Goals.

Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health

Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.

GLP-1 drugs like Ozempic have transformed weight management, but concerns around muscle loss, bone density, dampened desire, and dependency are growing

Insulin and incretins are compounds with multiple effects on neurodegenerative processes

While medications that reduce alcohol intake such as naltrexone and acamprosate have central nervous system action, disulfiram reduces alcohol intake through peripheral mechanisms